Pedullà Marcella, Fierro Vincenzo, Marzuillo Pierluigi, Capuano Francesco, Miraglia Del Giudice Emanuele, Ruocco Eleonora
Marcella Pedullà, Vincenzo Fierro, Pierluigi Marzuillo, Francesco Capuano, Emanuele Miraglia del Giudice, Department of Woman, Child and General and Specialized Surgery, Seconda Università degli Studi di Napoli, 80138 Napoli, Italy.
World J Clin Pediatr. 2016 Aug 8;5(3):288-92. doi: 10.5409/wjcp.v5.i3.288.
To verify the prevalence of thyroid autoimmunity (TA) and the possible association between atopy and TA in children affected by skin disease.
Three hundred and twenty-four children consecutively referred due to skin disease symptoms to our Pediatric Department were enrolled. One hundred and eighty-seven were diagnosed with atopic dermatitis (AD), 95 with acute urticaria, 40 with chronic urticaria (CU), and 2 with alopecia areata (AA). According to the work-up for atopy, the children were divided into two groups: Atopics and non-atopics. TA was diagnosed by serum thyroid peroxidase autoantibodies and/or thyroglobulin autoantibodies levels more than twice normal values over a period of two months by immunoassay.
In all children with skin disease, a significant prevalence of TA in atopics compared with non-atopics (13.67% vs 2.67%, P = 0.0016) and a significant association between TA and atopy (OR = 5.76, 95%CI: 1.71-19.35) were observed. These findings were confirmed as significant in children with AD: TA in atopics was 11.5%, while TA in non-atopics was 2.7% (P = 0.03, OR = 4.68, 95%CI: 1.02-21.38). In addition, atopics with CU showed a significantly higher prevalence of TA (26.9%), but none of the non-atopics showed CU (P = 0.0326). On the other hand, atopics with AA showed a 100% (2 out of 2) prevalence of TA, compared with none of the non-atopics.
In children with skin disease, atopy seems to be associated with an increased risk of TA.
验证皮肤病患儿中甲状腺自身免疫(TA)的患病率以及特应性与TA之间的可能关联。
连续纳入因皮肤病症状转诊至我院儿科的324名儿童。其中187名被诊断为特应性皮炎(AD),95名患有急性荨麻疹,40名患有慢性荨麻疹(CU),2名患有斑秃(AA)。根据特应性检查结果,将儿童分为两组:特应性组和非特应性组。通过免疫测定法,在两个月内血清甲状腺过氧化物酶自身抗体和/或甲状腺球蛋白自身抗体水平超过正常值两倍则诊断为TA。
在所有皮肤病患儿中,观察到特应性组的TA患病率显著高于非特应性组(13.67%对2.67%,P = 0.0016),且TA与特应性之间存在显著关联(OR = 5.76,95%CI:1.71 - 19.35)。这些发现在AD患儿中也被证实具有显著性:特应性组的TA患病率为11.5%,而非特应性组为2.7%(P = 0.03,OR = 4.68,95%CI:1.02 - 21.38)。此外,CU患儿中的特应性组TA患病率显著更高(26.9%),但非特应性组中无CU患儿(P = 0.0326)。另一方面,AA患儿中的特应性组TA患病率为100%(2/2),而非特应性组均无TA。
在皮肤病患儿中,特应性似乎与TA风险增加有关。